Salivary microRNA in Endometriosis: Correlation With Response to Progestin Therapy - Trial NCT06414720
Access comprehensive clinical trial information for NCT06414720 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Udine and is currently Recruiting. The study focuses on Endometriosis. Target enrollment is 90 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Udine
Timeline & Enrollment
N/A
Apr 22, 2024
May 01, 2025
Primary Outcome
response to the progestin therapy,changes in quality of life,differences in salivary miRNoma
Summary
This study aims to analyze the salivary miRNA specific for patients diagnosed with
 endometriosis, specifically evaluating the miRNA profile of patients who respond versus those
 who do not respond to progestin therapy. Ninety patients attending the Chronic Pelvic Pain
 Clinic will be recruited, and they will be asked to provide a saliva sample before starting
 medical therapy. The response to the therapy will be evaluated after 4 months from the
 beginning of the therapy itself.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06414720
Non-Device Trial